Fred Alger Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Fred Alger Management’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-14,000	Closed	-$762K	–	614
2019 Q4	$762K	Sell	14,000 -4,000	-22%	-$198K	﹤0.01%	363
2019 Q3	$751K	Sell	18,000 -2,000	-10%	-$84.5K	﹤0.01%	352
2019 Q2	$876K	Buy	+20,000	New	+$1.13M	﹤0.01%	350

Other funds holding BHVN

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

RP Management New York $139M AUM 37.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Fred Alger Management's BHVN Position: Q1 2020 in Review

Fred Alger Management sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q1 2020, closing a stake of 14,000 shares — an estimated $762K sold.

Fred Alger Management first reported a position in BHVN in Q2 2019 and held it in 3 quarters. The position peaked at $876K in Q2 2019. 175 funds tracked by Wall St. Rank hold BHVN as of Q1 2020.

Fred Alger Management reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q1 2020 after selling out during the quarter.
Fred Alger Management sold 14,000 Biohaven Pharmaceutical Holding Company Ltd. shares in Q1 2020, an estimated $762K.
Fred Alger Management first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2019 and held it in 3 quarters.
Fred Alger Management's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $876K in Q2 2019.
175 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q1 2020.

Based on Fred Alger Management's 13F filing for Q1 2020, filed 15 May 2020.